Fundraising Fox
Cytovation
Bergen, NO · Founded 2015 · 13 employees on LinkedIn · 2 known investors
Find your way into Cytovation
Cytovation develops immunotherapy treatments designed to enhance immune response against various cancer types, with a focus on engineered synthetic peptides and first-in-class therapeutic candidates. The company is built on research foundations from Norwegian academic institutions and serves oncology and immunology markets.
Founders & leadership
Cytovation was founded in 2015 by Lars Prestegarden.
Investors · 2
How we know: Sandwater's portfolio page · funding news · globenewswire.com · Not right? Tell us
How we know: globenewswire.com · Not right? Tell us
Funding
SEC filings, press & company announcements$14M disclosed across 2 rounds · 2023–2025
- $6MraisedApr 2025 · 2 sources
Sandwater (lead)
Source ↗ - $8MSeries A extension financing roundJun 2023 · 3 sources
Canica (lead), Sandwater (lead)
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Cytovation do?
- Cytovation develops immunotherapy treatments designed to enhance immune response against various cancer types, with a focus on engineered synthetic peptides and first-in-class therapeutic candidates. The company is built on research foundations from Norwegian academic institutions and serves oncology and immunology markets.
- Who founded Cytovation?
- Cytovation was founded by Lars Prestegarden in 2015.
- Who are Cytovation's investors?
- Cytovation's investors include Sandwater, Canica.
- How much funding has Cytovation raised?
- Cytovation has disclosed $14M raised across 2 rounds.
- Where is Cytovation headquartered?
- Cytovation is headquartered in Bergen, NO.